New model of erbB-2 over-expression in human mammary luminal epithelial cells

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 477-484

  Harris, Robert A ^a,c   Eichholtz, Thomas J ^a   Hiles, Ian D ^a   Page, Martin J ^a   O'Hare, Michael J ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; GLYCOSYLATED PROTEIN; LIGAND; NEU DIFFERENTIATION FACTOR; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; TYROSINE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL IMMORTALIZATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BREAST; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; COLLAGEN; DRUG COMBINATIONS; EPITHELIAL CELLS; FEMALE; HUMANS; LAMININ; PROTEOGLYCANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032933182     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<477::AID-IJC23>3.0.CO;2-W     Document Type: Article

References (26)

1. ALIMANDI, M., WANG, L.-M., BOTTARO, D., LEE, C.-C., KUO, A., FRANKEL, M., FEDI, P., TANG, C., LIPPMAN, M. and PIERCE, J.H., Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J., 16, 5608-5617 (1997).
2. BAULIDA, J., KRAUS, M.H., ALIMANDI, M., DIFIORE, P.P. and CARPENTER, G., All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. biol. Chem., 271, 5251-5257 (1996).
3. BUSMANIS, I., FELEPPA, F., JONES, A., MCGRATH, K.M., REED, R., COLLINS, J., RUSSELL, I. and BEGLEY, C.G., Analysis of c-erbB2 expression using a panel of 6 commercially available antibodies. Pathology, 26, 261-267 (1994).
4. CARRAWAY III, K.L., SLIWKOWSKI, M.X., AKITA, R., PLATKO, J.V., GUY, P.M., NUIJENS, A., DIAMONTI, A.J., VANDLEN, R.L., CANTLEY, L.C. and CERIONE, R.A., The erbB3 gene product is a receptor for heregulin. J. biol. Chem., 269, 14303-14306 (1994).
5. DIFIORE, P.P., PIERCE, J.H., KRAUS, M.H., SEGATTO, O., KING, C.R. and AARONSON, S.A., ErbB-2 is a potent oncogene when overexpressed in NIH 3T3 cells. Science, 237, 178-182 (1987).
6. DOUGALL, W.C., QIAN, X., PETERSON, N.C., MILLER, M.J., SAMANTA, A. and GREENE, M.I., The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 9, 2109-2123 (1994).
7. D'SOUZA, B., BERDICHEVSKY, F., KYPRIANOU, N. and TAYLOR-PAPADIMITRIOU, J., Collagen-induced morphogenesis and expression of the α2-integrin subunit is inhibited in c-erbB-2-transfected human mammary epithelial cells. Oncogene, 8, 1797-1806 (1993).
8. GRAUS-PORTA, D., BEERLI, R.R., DALY, J.M. and HYNES, N.E., ErbB-2, the preferred heterodimerisation partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16, 1647-1655 (1997).
9. GUSTERSON, B.A. and 20 OTHERS, Prognostic importance of c-erbB-2 expression in breast cancer. J. clin. Oncol., 10, 1049-1056 (1992).
10. HARRIS, R.A., HILES, I.D., PAGE, M.J. and O'HARE, M.J., The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Brit. J. Cancer, 72, 276-282 (1995).
11. JANES, P.W., DALY, R.J., DEFAZIO, A. and SUTHERLAND, R.L., Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene, 9, 3601-3608 (1994).
12. JAT, P.S. and SHARP, P.A., Cell lines established by a temperature-sensitive simian virus 40 large T antigen gene are growth restricted at the nonpermissive temperature. Mol. cell. Biol., 9, 1672-1681 (1989).
13. KARUNAGARAN, D., TZAHAR, E., BEERLI, R.R., CHEN, X., GRAUS-PORTA, D., RATZKIN, B.J., SEGER, R., HYNES, N.E. and YARDEN, Y., ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264 (1996).
14. KOKAI, Y., MYERS, J.N., WADA, T., BROWN, V.I., LEVEA, C.M., DAVIS, J.G., DOBASHI, I.K. and GREENE, M.I., Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292 (1989).
15. LEWIS, G.D., LOFGREN, J.A., MCMURTREY, A.E., NIJENS, A., FENDLY, B.M., BAUER, K.D. and SLIWKOWSKI, M.X., Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB-2 as a critical component in mediating heregulin responsiveness. Cancer Res., 56, 1457-1465 (1996).
16. O'HARE, M.J., ORMEROD, M.G., MONAGHAN, P., LANE, E.B. and GUSTERSON, B.A., Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. Differentiation. 46, 209-221 (1991).
17. PELICCI, G., LANFRANCONE, L., SALCINI, A.E., ROMANO, A., MELE, S., BORRELLO, M.G., SEGATTO, O., DIFIORE, P.P. and PELICCI, P.G., Constitutive phosphorylation of Shc proteins in human tumours. Oncogene, 11, 899-907 (1995).
18. PIERCE, J.H., ARNSTEIN, P., DIMARCO, E., ARTRIP, J., KRAUS, M.H., LONARDO, F., DIFIORE, P.P. and AARONSON, S.A., Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene, 6, 1189-1194 (1991).
19. PINKAS-KRAMARSKI, R., ALROY, I. and YARDEN, Y., ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling. J. Mammary Gland Biol. Neoplasia, 2, 97-107 (1997).
20. RIESE II, D.J., RAAIJ, T.M.V., PLOWMAN, G.D., ANDREWS, G.C. and STERN, D.F., The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. cell. Biol., 15, 5770-5776 (1995).
21. ROZAKIS-ADCOCK, M., MCGLADE, J., MBAMALU, G., PELICCI, G., DALY, R., LI, W., BATZER, A., THOMAS, S., BRUGGE, J., PELICCI, P.G., SCHLESSINGER, J. and PAWSON, T., Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature (Lond.), 360, 689-692 (1992).
22. SEGATTO, O., PELICCI, G., GIULI, S., DIGIESI, G., DIFIORE, P.P., MCGLADE, J., PAWSON, T. and PELICCI, P.G., Shc products are substrates of erbB-2 kinase. Oncogene, 8, 2105-2112 (1993).
23. STAMPS, A.C., DAVIES, S.C., BURMAN, J. and O'HARE, M.J., Analysis of proviral integration in human mammary epithelial cell lines immortalised by retroviral infection with a temperature-sensitive SV40 T-antigen construct. Int. J. Cancer, 57, 1-10 (1994).
24. TANG, C.K., PEREZ, C., GRUNT, T., WAIBEL, C., CHO, C. and LUPU, R., Involvement of heregulin-b2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res., 56, 3350-3358 (1996).
25. TAYLOR-PAPADIMITRIOU, J. and LANE, E.B., Keratin expression in the mammary gland. In: M.C. Neville and C.W. Daniels (eds.), The mammary gland, pp. 181-215, Plenum, New York (1987).
26. TZAHAR, E., WATERMAN, H., CHEN, X., LEVKOWITZ, G., KARUNAGARAN, D., LAVI, S., RATZKIN, B.J. and YARDEN, Y., A hierarchial network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol. cell. Biol., 16, 5276-5287 (1996).